Syros Pharmaceuticals Inc (SYRS)
5.11
+0.11
(+2.20%)
USD |
NASDAQ |
May 31, 16:00
5.10
-0.01
(-0.20%)
After-Hours: 20:00
Syros Pharmaceuticals Market Cap: 136.58M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 136.58M |
| May 30, 2024 | 133.64M |
| May 29, 2024 | 134.98M |
| May 28, 2024 | 133.64M |
| May 24, 2024 | 132.84M |
| May 23, 2024 | 137.65M |
| May 22, 2024 | 143.26M |
| May 21, 2024 | 151.01M |
| May 20, 2024 | 149.95M |
| May 17, 2024 | 145.67M |
| May 16, 2024 | 146.47M |
| May 15, 2024 | 147.27M |
| May 14, 2024 | 145.13M |
| May 13, 2024 | 135.25M |
| May 10, 2024 | 132.84M |
| May 09, 2024 | 133.91M |
| May 08, 2024 | 133.64M |
| May 07, 2024 | 137.65M |
| May 06, 2024 | 135.78M |
| May 03, 2024 | 137.12M |
| May 02, 2024 | 138.99M |
| May 01, 2024 | 145.40M |
| April 30, 2024 | 144.33M |
| April 29, 2024 | 143.80M |
| April 26, 2024 | 134.71M |
| Date | Value |
|---|---|
| April 25, 2024 | 136.31M |
| April 24, 2024 | 135.51M |
| April 23, 2024 | 137.38M |
| April 22, 2024 | 133.37M |
| April 19, 2024 | 121.35M |
| April 18, 2024 | 126.16M |
| April 17, 2024 | 136.58M |
| April 16, 2024 | 148.61M |
| April 15, 2024 | 143.00M |
| April 12, 2024 | 144.07M |
| April 11, 2024 | 158.23M |
| April 10, 2024 | 147.81M |
| April 09, 2024 | 147.01M |
| April 08, 2024 | 120.28M |
| April 05, 2024 | 124.82M |
| April 04, 2024 | 128.83M |
| April 03, 2024 | 133.11M |
| April 02, 2024 | 123.89M |
| April 01, 2024 | 134.71M |
| March 28, 2024 | 141.53M |
| March 27, 2024 | 154.49M |
| March 26, 2024 | 165.34M |
| March 25, 2024 | 169.30M |
| March 22, 2024 | 165.87M |
| March 21, 2024 | 167.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.64M
Minimum
Sep 07 2022
840.15M
Maximum
Jan 19 2021
243.51M
Average
211.78M
Median
Nov 11 2019
Market Cap Benchmarks
| PDS Biotechnology Corp | 109.49M |
| PAVmed Inc | 13.77M |
| Moderna Inc | 54.63B |
| Altimmune Inc | 532.48M |
| iBio Inc | 20.52M |
Market Cap Related Metrics
| PS Ratio | 16.00 |
| Price to Book Value | 9.071 |
| Price | 5.11 |
| Earnings Yield | -98.83% |